As filed with the Securities and Exchange Commission on May 29, 2020
Registration Statement No. 333-238678
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-1
REGISTRATION STATEMENT
UNDER
THE
SECURITIES ACT OF 1933
VIELA BIO, INC.
(Exact
name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
2834
|
|
82-4187338
|
(State or other jurisdiction of
incorporation or organization)
|
|
(Primary Standard Industrial
Classification Code Number)
|
|
(I.R.S. Employer
Identification Number)
|
One MedImmune Way
First Floor, Area Two
Gaithersburg, MD 20878
(240) 558-0038
(Address, including zip code, and telephone number, including area code, of registrants principal executive offices)
Zhengbin (Bing) Yao, Ph.D.
Chairman, President and Chief Executive Officer
Viela Bio, Inc.
One
MedImmune Way
First Floor, Area Two
Gaithersburg, MD 20878
(240) 558-0038
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
|
|
|
|
|
Jonathan L. Kravetz
John T. Rudy
Christopher
E. Jeffers, Ph.D.
Mintz, Levin, Cohn, Ferris, Glovsky &
Popeo, P.C.
One Financial
Center
Boston, MA 02111
(617) 542-6000
|
|
Mitchell Chan
Chief Financial Officer
Viela Bio, Inc.
One
MedImmune Way
First Floor, Area Two
Gaithersburg, MD 20878
(240) 558-0038
|
|
Patrick OBrien
Ropes & Gray LLP
Prudential Tower
800
Boylston Street
Boston, MA 02199
(617) 951-7000
|
Approximate date of commencement of proposed sale to the public:
As soon as practicable after the effective date of this registration statement.
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, as amended, check the following box. ☐
If this Form is filed to register additional securities for an offering pursuant to Rule
462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective
amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration number of the earlier effective registration statement for the same offering. ☒ (File No. 333-238678)
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer,
a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting
company and emerging growth company in Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
|
Large accelerated filer
|
|
☐
|
|
Accelerated filer
|
|
☐
|
|
|
|
|
Non-accelerated filer
|
|
☒
|
|
Smaller reporting company
|
|
☐
|
|
|
|
|
|
|
|
|
Emerging growth company
|
|
☒
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided to Section 7(a)(2)(B) of the Securities Act. ☐
The Registration Statement
shall become effective upon filing in accordance with Rule 462(d) promulgated under the Securities Act of 1933, as amended.
EXPLANATORY NOTE
This
Post-Effective Amendment No. 1 (Amendment No. 1) to the Registration Statement on Form S-1 (Registration Statement) is being filed solely for the purpose of refiling
Exhibit 5.1 with modifications. This Amendment No. 1 does not modify any provision of Part I or Part II of the Registration Statement other than Item 16(a) of Part II as set forth below.